Revisiting HER2 in Prostate Cancer from an Inclusive Perspective: From Biomarkers to Omics.

Saved in:
Bibliographic Details
Title: Revisiting HER2 in Prostate Cancer from an Inclusive Perspective: From Biomarkers to Omics.
Authors: Mavingire N; Department of Surgery, Morehouse School of Medicine, Atlanta, GA 30310, USA., Moore JC; Department of Surgery, Morehouse School of Medicine, Atlanta, GA 30310, USA., Johnson JR; Department of Microbiology, Biochemistry, & Immunology, Morehouse School of Medicine, Atlanta, GA 30310, USA., Dwead AM; Department of Surgery, Morehouse School of Medicine, Atlanta, GA 30310, USA., Cropp CD; Department of Pharmacology & Toxicology, Morehouse School of Medicine, Atlanta, GA 30310, USA., Mechref Y; Department of Chemistry and Biochemistry, Texas Tech University, Lubbock, TX 79409, USA., Kobeissy F; Department of Neurobiology, Morehouse School of Medicine, Atlanta, GA 30310, USA., Rais-Bahrami S; Department of Urology, University of Alabama at Birmingham Heersink School of Medicine, Birmingham, AL 35294, USA.; Department of Radiology, University of Alabama at Birmingham Heersink School of Medicine, Birmingham, AL 35294, USA.; O'Neal Comprehensive Cancer Center, University of Alabama at Birmingham Heersink School of Medicine, Birmingham, AL 35294, USA., Woods-Burnham L; Department of Surgery, Morehouse School of Medicine, Atlanta, GA 30310, USA.
Source: Cancers [Cancers (Basel)] 2024 Sep 25; Vol. 16 (19). Date of Electronic Publication: 2024 Sep 25.
Publication Type: Journal Article; Review
Journal Info: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101526829 Publication Model: Electronic Cited Medium: Print ISSN: 2072-6694 (Print) Linking ISSN: 20726694 NLM ISO Abbreviation: Cancers (Basel) Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:2072-6694
DOI:10.3390/cancers16193262